1129 related articles for article (PubMed ID: 19204465)
21. Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy.
Meyerand ME; Pipas JM; Mamourian A; Tosteson TD; Dunn JF
AJNR Am J Neuroradiol; 1999 Jan; 20(1):117-23. PubMed ID: 9974066
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma.
Alexander A; Murtha A; Abdulkarim B; Mehta V; Wheatley M; Murray B; Riauka T; Hanson J; Fulton D; McEwan A; Roa W
Clin Invest Med; 2006 Oct; 29(5):301-11. PubMed ID: 17144440
[TBL] [Abstract][Full Text] [Related]
23. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.
Lai PH; Hsu SS; Ding SW; Ko CW; Fu JH; Weng MJ; Yeh LR; Wu MT; Liang HL; Chen CK; Pan HB
Surg Neurol; 2007; 68 Suppl 1():S25-36. PubMed ID: 17963918
[TBL] [Abstract][Full Text] [Related]
24. Cerebral blood volume measurements and proton MR spectroscopy in grading of oligodendroglial tumors.
Spampinato MV; Smith JK; Kwock L; Ewend M; Grimme JD; Camacho DL; Castillo M
AJR Am J Roentgenol; 2007 Jan; 188(1):204-12. PubMed ID: 17179366
[TBL] [Abstract][Full Text] [Related]
25. Effect of Gd-DTPA-BMA on choline signals of HT29 tumors detected by in vivo 1H MRS.
Madhu B; Robinson SP; Howe FA; Griffiths JR
J Magn Reson Imaging; 2008 Nov; 28(5):1201-8. PubMed ID: 18972329
[TBL] [Abstract][Full Text] [Related]
26. In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy.
Sardanelli F; Fausto A; Di Leo G; de Nijs R; Vorbuchner M; Podo F
AJR Am J Roentgenol; 2009 Jun; 192(6):1608-17. PubMed ID: 19457825
[TBL] [Abstract][Full Text] [Related]
27. [Application value of 3T 1H-magnetic resonance spectroscopy in diagnosing tumors of bone and soft tissue].
Qi ZH; Li CF; Ma XX; Li ZF; Zhang K; Yu DX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Oct; 33(5):504-10. PubMed ID: 22338133
[TBL] [Abstract][Full Text] [Related]
28. Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors.
Herminghaus S; Pilatus U; Möller-Hartmann W; Raab P; Lanfermann H; Schlote W; Zanella FE
NMR Biomed; 2002 Oct; 15(6):385-92. PubMed ID: 12357552
[TBL] [Abstract][Full Text] [Related]
29. Combined DCE-MRI and single-voxel 2D MRS for differentiation between benign and malignant breast lesions.
Lipnick S; Liu X; Sayre J; Bassett LW; Debruhl N; Thomas MA
NMR Biomed; 2010 Oct; 23(8):922-30. PubMed ID: 20878970
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
[TBL] [Abstract][Full Text] [Related]
31. In vivo 1H MRS for musculoskeletal lesion characterization: which factors affect diagnostic accuracy?
Wang CK; Li CW; Hsieh TJ; Lin CJ; Chien SH; Tsai KB; Chang KC; Tsai HM
NMR Biomed; 2012 Feb; 25(2):359-68. PubMed ID: 21793078
[TBL] [Abstract][Full Text] [Related]
32. Identification of prognostic markers in bone sarcomas using proton-decoupled phosphorus magnetic resonance spectroscopy.
Zakian KL; Shukla-Dave A; Meyers P; Gorlick R; Healey J; Thaler HT; Huvos AG; Panicek DM; Koutcher JA
Cancer Res; 2003 Dec; 63(24):9042-7. PubMed ID: 14695223
[TBL] [Abstract][Full Text] [Related]
33. Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas.
Demir MK; Iplikcioglu AC; Dincer A; Arslan M; Sav A
Eur J Radiol; 2006 Oct; 60(1):48-55. PubMed ID: 16844335
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer.
Jagannathan NR; Kumar M; Seenu V; Coshic O; Dwivedi SN; Julka PK; Srivastava A; Rath GK
Br J Cancer; 2001 Apr; 84(8):1016-22. PubMed ID: 11308247
[TBL] [Abstract][Full Text] [Related]
35. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
36. Proton MR spectroscopy of the prostate.
Mueller-Lisse UG; Scherr MK
Eur J Radiol; 2007 Sep; 63(3):351-60. PubMed ID: 17709223
[TBL] [Abstract][Full Text] [Related]
37. Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study.
Matsumura A; Isobe T; Anno I; Takano S; Kawamura H
J Clin Neurosci; 2005 May; 12(4):416-20. PubMed ID: 15925772
[TBL] [Abstract][Full Text] [Related]
38. In vivo proton magnetic resonance spectroscopy of breast lesions: an update.
Tse GM; Yeung DK; King AD; Cheung HS; Yang WT
Breast Cancer Res Treat; 2007 Sep; 104(3):249-55. PubMed ID: 17051424
[TBL] [Abstract][Full Text] [Related]
39. [Oral-maxillofacial malignant tumors: an initial study with in vivo single-voxel 1H MR spectroscopy].
Yu Q; Wang PZ; Shi HM; Luo JC
Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Jan; 42(1):18-20. PubMed ID: 17331436
[TBL] [Abstract][Full Text] [Related]
40. Noninvasive evaluation of cerebral glioma grade by using multivoxel 3D proton MR spectroscopy.
Zeng Q; Liu H; Zhang K; Li C; Zhou G
Magn Reson Imaging; 2011 Jan; 29(1):25-31. PubMed ID: 20832225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]